SCHEMBL81131

SCHEMBL81131

COc1ccc(Br)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 2/20 0.47
▸ ALOX15 P16050 1/20 0.46
▸ MAPT P10636 3/20 0.46
▸ THRB P10828 1/20 0.46
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ ACHE P22303 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30970345 1.00 NQO2 (0.47) NQO2ALOX15MAPTTHRBNPC1
SCHEMBL17351634 0.98 NQO2 (0.46) NQO2ALOX15MAPTTHRBNPC1
SCHEMBL5327500 0.84 MAPT (0.43) NQO2ALOX15MAPTTHRBNPC1
SCHEMBL14499435 0.83 PDGFRB (0.49) NQO2ALOX15MAPTTHRBALDH1A1
SCHEMBL17151135 0.81 PTGS2 (0.44) NQO2MAPTTHRBNPC1RAB9A
SCHEMBL29426969 0.81 KDM4E (0.43) NQO2MAPTNPC1RAB9AALDH1A1
SCHEMBL5156534 0.81 KDM4E (0.43) NQO2MAPTNPC1RAB9AALDH1A1
SCHEMBL29419589 0.80 CA2 (0.56) MAPTALDH1A1L3MBTL1TDP1ACHE
SCHEMBL20509 0.80 CA2 (0.56) MAPTALDH1A1L3MBTL1TDP1ACHE
SCHEMBL30760975 0.80 ATM (0.43) MAPTRAB9AALDH1A1L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 668 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119191946-B Electrophilic cross-coupling method of aryl perfluoro butyl sulfonate and aryl bromide 南京工业大学 2026-05-15 — — CN claimed
CN-118955262-A Direct cross-coupling method of pyridine ester and aryl bromide 南京工业大学 2024-11-15 — — CN claimed
CN-116041153-B Direct cross coupling method of aryl thioether and aryl bromine 南京工业大学 2024-05-24 — — CN claimed
CN-116253623-B Direct cross-coupling method of aryl fluorine sulfate and aryl bromine 南京工业大学 2024-04-05 — — CN claimed
CN-114591128-B Direct cross-coupling method of aryl sulfide salt and aryl bromide 南京工业大学 2023-08-22 — — CN claimed
CN-116573994-A Direct cross-coupling method of triazine ester and aryl bromide 南京工业大学 2023-08-11 — — CN claimed
CN-116554009-A Electrophilic cross-coupling reaction method of aryl sulfone or heteroaryl sulfone and aryl bromide 南京工业大学 2023-08-08 — — CN claimed
CN-116283515-A Direct cross coupling method of aryl fluoride and aryl bromide 南京工业大学 2023-06-23 — — CN claimed
CN-116253623-A Direct cross-coupling method of aryl fluorine sulfate and aryl bromine 南京工业大学 2023-06-13 — — CN claimed
CN-116041153-A Direct cross coupling method of aryl thioether and aryl bromine 南京工业大学 2023-05-02 — — CN claimed
CN-113387876-A Nickel-catalyzed direct reduction cross-coupling method for heterocyclic phosphonium salt and aryl bromide and product 南京工业大学 2021-09-14 — — CN claimed
EP-3692101-A1 BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES Alfa Instruments S.r.l. (IT) 2020-08-12 — — EP claimed
WO-2019068935-A1 BRILLIANT BLUE (BBG) DYE DERIVATIVES AND STAINING COMPOSITIONS COMPRISING THE SAME FOR SELECTIVELY STAINING BIOLOGICAL SUBSTRATES ALFA INSTRUMENTS S.R.L. (IT) 2019-04-11 — — WO claimed
US-9997714-B2 Hole transport material MERCK PATENT GMBH (DE) 2018-06-12 — — US claimed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 — — EP claimed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 — — US claimed
EP-2183239-A1 SULFONAMIDES AS TRPM8 MODULATORS Janssen Pharmaceutica, N.V. (BE) 2010-05-12 — — EP claimed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 — — US claimed
WO-2009012430-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2009-01-22 — — WO claimed
US-5008464-A Anisole bromination EAST SHORT CHEMICAL COMPANY (US) 1991-04-16 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 NQO2 1677/4885ALOX15 3450/4885MAPT 3324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback